Cart
sales@molnova.com
SR3335
CAS No. 293753-05-6
SR3335( ML 176 )
Catalog No. M19947 CAS No. 293753-05-6
SR 3335 is a selective inverse agonist of RORα competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki: 220 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 232 | In Stock |
|
| 50MG | 430 | In Stock |
|
| 100MG | 620 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSR3335
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR 3335 is a selective inverse agonist of RORα competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki: 220 nM).
-
DescriptionSR 3335 is a selective inverse agonist of RORα competitively inhibiting the binding of 25-hydroxycholesterol to the ligand binding domain (Ki: 220 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsML 176
-
PathwayNuclear Receptor/Transcription Factor
-
TargetROR
-
RecptorRORα
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number293753-05-6
-
Formula Weight405.34
-
Molecular FormulaC13H9F6NO3S2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 30 mg/mL;DMSO: 40 mg/mL
-
SMILESOC(c1ccc(NS(=O)(=O)c2cccs2)cc1)(C(F)(F)F)C(F)(F)F
-
Chemical NameN-[4-[222-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kumar N et al. Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist. ACS Chem Biol. 2011 Mar 18;6(3):218-22.
molnova catalog
related products
-
SR1001
SR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).
-
SR2211
SR2211 is a specific modulator and an inverse agonist of RORγ(IC50 = 320 nM, Ki = 105 nM).
-
XY018
XY018 is an orally available, selective and highly effective ROR-γ antagonist with antitumor activity, inhibits ROR-γ activity, inhibits tumor cell growth, and can be used to study drug-resistant prostate cancer.
